Adani Wilmar Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 1:41 pm

Quick Insight

Adani Wilmar Ltd, with a share price of ₹257 and a market cap of ₹33,434 Cr., exhibits a P/E ratio of 29.1, ROE of 13.9%, and ROCE of 20.9%. Operating at a 2% OPM, the company generated a net profit of ₹1,226 Cr. Promoters hold a significant stake at 87.88%, while FIIs and DIIs have minimal holdings at 0.95% and 0.07%, respectively. With a P/BV of 5.02x and an ICR of 1.91x, Adani Wilmar's financial health seems robust, backed by reserves of ₹9,294 Cr. Despite a lack of clarity on the CCC, the company's strong fundamentals and diversified shareholder base of 10,75,647 individuals position it well for potential growth and stability in the edible oils and solvent extraction industry.

Competitors of Adani Wilmar Ltd

All Competitor Stocks of Adani Wilmar Ltd

Quarterly Result

Last Updated: July 16, 2025, 3:30 pm

Below is a detailed analysis of the quarterly data for Adani Wilmar Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 17,059.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18,230.00 Cr. (Mar 2025) to 17,059.00 Cr., marking a decrease of 1,171.00 Cr..
• For Expenses, as of Jun 2025, the value is 16,693.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17,771.00 Cr. (Mar 2025) to 16,693.00 Cr., marking a decrease of 1,078.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 366.00 Cr.. The value appears to be declining and may need further review. It has decreased from 458.00 Cr. (Mar 2025) to 366.00 Cr., marking a decrease of 92.00 Cr..
• For OPM %, as of Jun 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 3.00% (Mar 2025) to 2.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 206.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 206.00 Cr., marking an increase of 154.00 Cr..
• For Interest, as of Jun 2025, the value is 159.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 178.00 Cr. (Mar 2025) to 159.00 Cr., marking a decrease of 19.00 Cr..
• For Depreciation, as of Jun 2025, the value is 103.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.00 Cr. (Mar 2025) to 103.00 Cr., marking an increase of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 311.00 Cr.. The value appears strong and on an upward trend. It has increased from 234.00 Cr. (Mar 2025) to 311.00 Cr., marking an increase of 77.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 238.00 Cr.. The value appears strong and on an upward trend. It has increased from 191.00 Cr. (Mar 2025) to 238.00 Cr., marking an increase of 47.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.82. The value appears strong and on an upward trend. It has increased from 1.46 (Mar 2025) to 1.82, marking an increase of 0.36.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:39 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:59 pm

Below is a detailed analysis of the balance sheet data for Adani Wilmar Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 130.00 Cr..
• For Reserves, as of Mar 2025, the value is 9,294.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,186.00 Cr. (Mar 2024) to 9,294.00 Cr., marking an increase of 1,108.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,937.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,628.00 Cr. (Mar 2024) to 1,937.00 Cr., marking a decrease of 691.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 11,051.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,833.00 Cr. (Mar 2024) to 11,051.00 Cr., marking an increase of 2,218.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 22,412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,777.00 Cr. (Mar 2024) to 22,412.00 Cr., marking an increase of 2,635.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5,481.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,921.00 Cr. (Mar 2024) to 5,481.00 Cr., marking an increase of 560.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,060.00 Cr.. The value appears strong and on an upward trend. It has increased from 879.00 Cr. (Mar 2024) to 1,060.00 Cr., marking an increase of 181.00 Cr..
• For Investments, as of Mar 2025, the value is 624.00 Cr.. The value appears strong and on an upward trend. It has increased from 312.00 Cr. (Mar 2024) to 624.00 Cr., marking an increase of 312.00 Cr..
• For Other Assets, as of Mar 2025, the value is 15,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,665.00 Cr. (Mar 2024) to 15,248.00 Cr., marking an increase of 1,583.00 Cr..
• For Total Assets, as of Mar 2025, the value is 22,412.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,777.00 Cr. (Mar 2024) to 22,412.00 Cr., marking an increase of 2,635.00 Cr..

Notably, the Reserves (9,294.00 Cr.) exceed the Borrowings (1,937.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Adani Wilmar Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 23) to 1.14, marking a decrease of 3.34.
• For Diluted EPS (Rs.), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 23) to 1.14, marking a decrease of 3.34.
• For Cash EPS (Rs.), as of Mar 24, the value is 4.11. This value is within the healthy range. It has decreased from 7.02 (Mar 23) to 4.11, marking a decrease of 2.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 63.98. It has increased from 62.83 (Mar 23) to 63.98, marking an increase of 1.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 63.98. It has increased from 62.83 (Mar 23) to 63.98, marking an increase of 1.15.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 394.41. It has decreased from 447.68 (Mar 23) to 394.41, marking a decrease of 53.27.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 10.99. This value is within the healthy range. It has decreased from 14.79 (Mar 23) to 10.99, marking a decrease of 3.80.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.19. This value is within the healthy range. It has decreased from 12.03 (Mar 23) to 8.19, marking a decrease of 3.84.
• For PBT / Share (Rs.), as of Mar 24, the value is 2.02. This value is within the healthy range. It has decreased from 6.07 (Mar 23) to 2.02, marking a decrease of 4.05.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 2. It has decreased from 4.26 (Mar 23) to 1.31, marking a decrease of 2.95.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 2. It has decreased from 4.48 (Mar 23) to 1.14, marking a decrease of 3.34.
• For PBDIT Margin (%), as of Mar 24, the value is 2.78. This value is below the healthy minimum of 10. It has decreased from 3.30 (Mar 23) to 2.78, marking a decrease of 0.52.
• For PBIT Margin (%), as of Mar 24, the value is 2.07. This value is below the healthy minimum of 10. It has decreased from 2.68 (Mar 23) to 2.07, marking a decrease of 0.61.
• For PBT Margin (%), as of Mar 24, the value is 0.51. This value is below the healthy minimum of 10. It has decreased from 1.35 (Mar 23) to 0.51, marking a decrease of 0.84.
• For Net Profit Margin (%), as of Mar 24, the value is 0.33. This value is below the healthy minimum of 5. It has decreased from 0.95 (Mar 23) to 0.33, marking a decrease of 0.62.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 8. It has decreased from 1.00 (Mar 23) to 0.28, marking a decrease of 0.72.
• For Return on Networth / Equity (%), as of Mar 24, the value is 1.77. This value is below the healthy minimum of 15. It has decreased from 7.12 (Mar 23) to 1.77, marking a decrease of 5.35.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.33. This value is within the healthy range. It has decreased from 16.82 (Mar 23) to 11.33, marking a decrease of 5.49.
• For Return On Assets (%), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 2.77 (Mar 23) to 0.74, marking a decrease of 2.03.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.29. This value is within the healthy range. It has increased from 0.27 (Mar 23) to 0.29, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 2.51. It has decreased from 2.70 (Mar 23) to 2.51, marking a decrease of 0.19.
• For Current Ratio (X), as of Mar 24, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 23) to 1.22, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 23) to 0.53, marking a decrease of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.82. This value is within the healthy range. It has decreased from 6.15 (Mar 23) to 5.82, marking a decrease of 0.33.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 1.91. This value is below the healthy minimum of 3. It has decreased from 2.48 (Mar 23) to 1.91, marking a decrease of 0.57.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.30. This value is below the healthy minimum of 3. It has decreased from 1.71 (Mar 23) to 1.30, marking a decrease of 0.41.
• For Enterprise Value (Cr.), as of Mar 24, the value is 41,339.18. It has decreased from 51,269.45 (Mar 23) to 41,339.18, marking a decrease of 9,930.27.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.80. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 23) to 0.80, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 24, the value is 28.93. This value exceeds the healthy maximum of 15. It has increased from 26.67 (Mar 23) to 28.93, marking an increase of 2.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 23) to 0.81, marking a decrease of 0.09.
• For Price / BV (X), as of Mar 24, the value is 5.02. This value exceeds the healthy maximum of 3. It has decreased from 6.46 (Mar 23) to 5.02, marking a decrease of 1.44.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 23) to 0.81, marking a decrease of 0.09.
• For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness